trending Market Intelligence /marketintelligence/en/news-insights/trending/kHjGXtSyu68gcoalp_j4gg2 content esgSubNav
In This List

Ascendis Pharma closes ADS offering

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Ascendis Pharma closes ADS offering

Ascendis Pharma A/S closed an underwritten public offering of 3.8 million American depositary shares for net proceeds of about $126.1 million.

The company priced the ADSs, each of which represents 1 ordinary share, at $35.50 apiece.

Underwriters also received a 30-day option to buy up to an additional 570,000 ADSs.

Underwriters were J.P. Morgan Securities LLC, Merrill Lynch, Pierce Fenner & Smith Inc., Credit Suisse Securities (USA) LLC, Wells Fargo Securities LLC and Wedbush Securities Inc.